Haemophilia Flashcards
What is haemophilia?
A bleeding disorder, usually inherited with an X-linked recessive inheritance pattern, which results from the deficiency of a coagulation factor leading to impaired secondary haemostasis.
What causes haemophilia?
- X-Linked ⇒ primarily affects males, females may be carriers and show mild symptoms (males only have one X chromosome, whereas females have two)
- ALMOST IMPOSSIBLE FOR FEMALE TO HAVE - Haemophilia A (80%) → deficiency of clotting factor 8
- Haemophilia B (20%) → deficiency of clotting factor 9
- Vitamin K deficiency
What are the risk factors for haemophilia?
Family history, Ashkenazi Jew
Summarise the epidemiology of haemophilia
Due to its inheritance pattern, Haemophilia is mainly seen in MALES
* Haemophilia A incidence: 1/10,000 males
* Haemophilia B incidence: 1/25,000 males
* Haemophilia C is more common in Ashkenazi Jews
What are the presenting symptoms of haemophilia?
- Symptoms usually begin in early childhood, or after surgery/trauma
- Swollen painful joints occurring spontaneously or with minimal trauma (haemarthroses)
- Painful bleeding into muscles causing haematomas – high pressure can lead to nerve palsies and compartment syndrome
- Haematuria
- Excessive bruising or bleeding after surgery or trauma
- FEMALE carriers are usually asymptomatic, but may experience excessive bleeding after trauma
- Generally speaking, bleeding in haemophilia is DEEP (into muscles and joints)
What signs of haemophilia can be found on physical examination?
- Multiple bruises
- Muscle haematomas
- Haemarthroses (bleeding into joints)
- Joint deformity
- Nerve palsies (due to nerve compression by haematomas)
- Signs of iron deficiency anaemia
What investigations are used to diagnose/ montior haemophilia?
- Prolonged APTT → factor 8 and 9 are in the intrinsic pathway
- Intrinsic Pathway (APTT) ⇒ 8,9,11,12
- Extrinsic Pathway (PT) ⇒ 3,7
- Common Pathway ⇒ 1,2,5,10,13 - Plasma Factor VIII and IX assay → confirm diagnosis
- PT (extrinsic pathway) and Bleeding Time → normal
- Mixing Study → requested if aPTT is prolonged. Correction of aPTT with mixing study suggests coagulation factor deficiency
- AST and ALT → liver dysfunction may contribute to prolonged PT and aPTT
How is haemophilia managed?
- Substitution of clotting factors → factor concentrates
- Desmopressin → may be given for mild haemophilia A. Triggers release of VWF from endothelial cells, leading to increase in factor VIII plasma concentration
- Antifibrinolytic Therapy (eg. Aminocaproic Acid or Tranexamic Acid) → inhibits break down of clots to reduce risk of bleeding
- Factor IX replacement: minimises the risk of complications
What complications may arise following haemophilia?
- Compartment syndrome
- Allergic reaction to infused product
- Joint and/or muscular damage
- Bleeding or life threatening haemorrhage
- Development of treatment related inhibitors to factor VIII or factor IX
- Blood-borne infections